BATS BZX Real-Time Price
As of 2:46pm ET
| +0.66 / +1.01%|
The 20 analysts offering 12-month price forecasts for ResMed Inc have a median target of 63.04, with a high estimate of 74.36 and a low estimate of 44.00. The median estimate represents a -4.18% decrease from the last price of 65.79.
The current consensus among 23 polled investment analysts is to Buy stock in ResMed Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.